2011 Annual Meeting | NIH/NINDS Colloquium
12:00 PM - 12:10 PM |
Clinical Tools from NIH to Clinicians
Walter J. Koroshetz, MD, FAAN |
|
12:10 PM - 01:00 PM |
Patient Reported Outcome Tools
David Cella, PhD, Lisa M. Shulman, MD, FAAN |
|
01:00 PM - 01:30 PM |
The Neurological Quality of Life Tool
Claudia Moy, PhD |
|
01:30 PM - 02:00 PM |
The NIH Toolbox of Validated Clinical Tests
Thomas P. Bleck, MD, FAAN |
Lisa M. Shulman, MD, FAAN | The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care. |
Walter J. Koroshetz, MD, FAAN | Dr. Koroshetz has nothing to disclose. |
Thomas P. Bleck, MD, FAAN | Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Bleck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for iECURE. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine. Dr. Bleck has received research support from NIH. |
Claudia Moy, PhD | Claudia Moy, PhD has nothing to disclose. |
David Cella, PhD | No disclosure on file |